Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma

Prenatal Diagnosis

Volumn 33, Issue 7, 2013, Pages 662-666

  Wang, Eric ^a   Batey, Annette ^a   Struble, Craig ^a   Musci, Thomas ^a   Song, Ken ^a   Oliphant, Arnold ^a  

^a Ariosa Diagnostics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL FREE DNA; DNA; UNCLASSIFIED DRUG;

ARTICLE; BLOOD SAMPLING; BODY WEIGHT; CELL FREE SYSTEM; DIAGNOSTIC TEST; DNA DETERMINATION; FEMALE; FETUS; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL PLASMA; MATERNAL WEIGHT; PREGNANCY; PRIORITY JOURNAL; REPEAT PROCEDURE;

BODY WEIGHT; DNA; FEMALE; FETUS; GENETIC TESTING; GESTATIONAL AGE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 84880043573     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4119     Document Type: Article

References (17)

1. Sparks AB, Wang ET, Struble Ca, et al. Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy. Prenat Diagn 2012;32(1):3-9.
2. Norton ME, Brar H, Weiss J, et al. Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012;207(2):137.e1-8.
3. Sparks AB, Struble Ca, Wang ZET, et al. Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18. Am J Obstet Gynecol. 2012;206(4):319.e1-9.
4. Nicolaides KH, Syngelaki A, Ashoor G, et al. Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population. Am J Obstet Gynecol 2012;207(5):374.e1-6.
5. Ashoor G, Syngelaki A, Wagner M, et al. Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012;206(4):322.e1-5.
6. Canick JA, Kloza EM, Lambert-Messerlian GM, et al. DNA sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations. Prenat Diagn 2012;32(8):730-4.
7. Bianchi DW, Platt LD, Goldberg JD, et al. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 2012;119(5):890-901.
8. Dan S, Wang W, Ren J, et al. Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11105 pregnancies with mixed risk factors. Prenat Diagn 2012:32(13):1225-32.
9. Chitty LS, Hill M, White H, et al. Noninvasive prenatal testing for aneuploidy-ready for prime time?. Am J Obstet Gynecol 2012;206(4):269-75.
10. ACOG Practice Bulletin. No. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol 2007;109(1):217-27.
11. Nicolaides KH. Screening for fetal aneuploidies at 11 to 13 weeks. Prenat Diagn 2011;31(1):7-15.
12. Zimmermann B, Hill M, Gemelos G, et al. Noninvasive prenatal aneuploidy testing of chromosomes 13, 18, 21, X, and Y using targeted sequencing of polymorphic loci. Prenat Diagn 2012;32(13):1-9.
13. Galbiati S, Smid M, Gambini D, et al. Fetal DNA detection in maternal plasma throughout gestation. Hum Genet 2005;117(2-3):243-8.
14. Brar H, Wang E, Struble C, et al. The fetal fraction of cell-free DNA in maternal plasma is not affected by a priori risk of fetal trisomy. The journal of maternal-fetal & neonatal medicine: the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 2012.
15. Ashoor G, Poon L, Syngelaki A, et al. Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks gestation: effect of maternal and fetal factors. Fetal Diagn Ther 2012;31(4):237-43.
16. Frankenfield DC, Rowe WA, Cooney RN, et al. Limits of body mass index to detect obesity and predict body composition. Nutrition 2001;17(1):26-30.
17. Fattah C, Farah N, Barry S, et al. The measurement of maternal adiposity. J Obstet Gynaecol 2009;29(8):686-9.